TOTAL IRON-BINDING CAPACITY CALIBRATOR SET. DIRECT TIBC CALIBRATOR SET
K052148 · Reference Diagnostics, Inc. · JIT · Nov 9, 2005 · Clinical Chemistry
Device Facts
| Record ID | K052148 |
| Device Name | TOTAL IRON-BINDING CAPACITY CALIBRATOR SET. DIRECT TIBC CALIBRATOR SET |
| Applicant | Reference Diagnostics, Inc. |
| Product Code | JIT · Clinical Chemistry |
| Decision Date | Nov 9, 2005 |
| Decision | SESE |
| Submission Type | Abbreviated |
| Regulation | 21 CFR 862.1150 |
| Device Class | Class 2 |
Intended Use
The RDI Direct TIBC Calibrator Set is intended for medical purposes for use with the RDI Direct TIBC Kit to establish points of reference that are used in the quantitative determination of Total Iron-Binding Capacity (TIBC) in human serum.
Device Story
Direct TIBC Calibrator Set functions as a reference standard for the RDI Direct TIBC Kit; used in clinical laboratory settings to calibrate quantitative assays for Total Iron-Binding Capacity in human serum. Provides established reference points to ensure accuracy of patient test results; assists clinicians in diagnosing iron-related disorders. Operated by laboratory technicians; results used to support clinical decision-making regarding iron status.
Clinical Evidence
No clinical data; bench testing only.
Technological Characteristics
In vitro diagnostic calibrator set; liquid or lyophilized reagent form; intended for use with specific TIBC assay kits; Class II device under 21 CFR 862.1150.
Indications for Use
Indicated for use as a reference standard in the quantitative determination of Total Iron-Binding Capacity (TIBC) in human serum samples.
Regulatory Classification
Identification
A calibrator is a device intended for medical purposes for use in a test system to establish points of reference that are used in the determination of values in the measurement of substances in human specimens. (See also § 862.2 in this part.)
Special Controls
*Classification.* Class II (special controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 862.9.
Related Devices
- K053291 — FERRITIN CALIBRATOR SET, CATALOG NO. 8203 · Reference Diagnostics, Inc. · Mar 13, 2006
- K994114 — DIMENSION TOTAL IRON BINDING CAPACITY (IBCT) CALIBRATOR · Dade Behring, Inc. · Jan 20, 2000
- K061251 — DIMENSION VISTA TOTAL IRON BINDING CAPACITY CALIBRATOR · Dade Behring, Inc. · May 31, 2006
- K163078 — DC-UIBC-CAL · Sekisui Diagnostics P.E.I., Inc. · Dec 8, 2016
- K990216 — MAGNETIC TIBC KIT · Reference Diagnostics, Inc. · Feb 16, 1999
Submission Summary (Full Text)
{0}------------------------------------------------
Image /page/0/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo consists of a circular seal with the words "DEPARTMENT OF HEALTH & HUMAN SERVICES • USA" arranged around the perimeter. Inside the circle is a stylized representation of three overlapping human profiles, suggesting a sense of community and connection.
Food and Drug Administration 2098 Gaither Road Rockville MD 20850
NOV - 9 2005
Joseph Lawlor, Ph.D. President Reference Diagnostics, Inc. 19 Crosby Drive Suite 30 Bedford, MA 01730
Re: k052148
> Trade/Device Name: Direct TIBC Calibrator Set Regulation Number: 21 CFR 862.1150 Regulation Name: Calibrator Regulatory Class: Class II Product Code: JIT Dated: October 25, 2005 Received: October 26, 2005
Dear Dr. Lawlor:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration. Iisting of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in Title 21, Code of Federal Regulations (CFR), Parts 800 to 895. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Parts 801 and 809); and good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820).
{1}------------------------------------------------
Page 2 -
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific information about the application of labeling requirements to your device, or questions on the promotion and advertising of your device, please contact the Office of In Vitro Diagnostic Device Evaluation and Safety at (240) 276-0484. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html.
Sincerely yours,
Alberto Gutierrez, Ph.D.
Alberto Gutierrez, Ph.D. Director Division of Chemistry and Toxicology Office of In Vitro Diagnostic Device Evaluation and Safety Center for Devices and Radiological Health
Enclosure
{2}------------------------------------------------
## Indications for Use
510(k) Number (if known):
K052148
Device Name:
Direct TIBC Calibrator Set
Indications For Use:
The RDI Direct TIBC Calibrator Set is intended for medical purposes for use with the RDI Direct TIBC Kit to establish points of reference that are used in the quantitative determination of Total Iron-Binding Capacity (TIBC) in human serum.
Prescription Use (Part 21 CFR 801 Subpart D) AND/OR
Over-The-Counter Use (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)
Concurrence of CDRH, Office of In Vitro Diagnostic Devices (OIVD)
Carol Benson
Division Sign-Off
Office of in Vitro Diagnostic Device Evaluation and Safety
STOKI
Page 1 of